盛禾生物委任姜晓玲为CEO兼首席科学官,履历涵盖金斯瑞、优科制药

瑞财经
Jan 26

瑞财经 刘治颖1月23日,盛禾生物-B(02898)公告,执行董事姜晓玲已获委任为公司首席执行官兼首席科学官,自2026年1月23日起生效。资料显示,姜晓玲,自2020年2月起加入集团,担任盛禾(中国)生物制药的副总经理及研发负责人。她于2023年7月21日获委任为董事并于2023年7月22日获调任为执行董事且进一步获委任为副总裁,负责管理研发部及产品注册。姜晓玲现时亦为盛禾(中国)生物制药、盛禾...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10